📗 Cite This Artifact
GEMIN8 Gene
GEMIN8 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GEMIN8 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GEMIN8</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Gem-Associated Protein 8</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>GEMIN8, SMN-associated protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xp21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[54935](https://www.ncbi.nlm.nih.gov/gene/54935)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[609653](https://www.omim.org/entry/609653)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000165275](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165275)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9BYX4](https://www.uniprot.org/uniprotkb/Q9BYX4/entry)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>346 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~37 kDa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
GEMIN8 Gene
Overview
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GEMIN8 Gene</th>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>GEMIN8</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Gem-Associated Protein 8</td>
</tr>
<tr>
<td class="label">Aliases</td>
<td>GEMIN8, SMN-associated protein</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>Xp21.3</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>[54935](https://www.ncbi.nlm.nih.gov/gene/54935)</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>[609653](https://www.omim.org/entry/609653)</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>[ENSG00000165275](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165275)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>[Q9BYX4](https://www.uniprot.org/uniprotkb/Q9BYX4/entry)</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>346 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~37 kDa</td>
</tr>
<tr>
<td class="label">Tissue</td>
<td>Expression Level</td>
</tr>
<tr>
<td class="label">Brain</td>
<td>High</td>
</tr>
<tr>
<td class="label">Spinal Cord</td>
<td>High</td>
</tr>
<tr>
<td class="label">Muscle</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Heart</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Liver</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Mechanism</td>
<td>Description</td>
</tr>
<tr>
<td class="label">SMN Deficiency</td>
<td>Loss of functional SMN protein reduces complex assembly</td>
</tr>
<tr>
<td class="label">snRNP Defects</td>
<td>Impaired spliceosomal function</td>
</tr>
<tr>
<td class="label">Splicing Dysregulation</td>
<td>Aberrant mRNA processing</td>
</tr>
<tr>
<td class="label">Motor Neuron Vulnerability</td>
<td>Selective degeneration</td>
</tr>
<tr>
<td class="label">SMA Type</td>
<td>Age of Onset</td>
</tr>
<tr>
<td class="label">Type 1</td>
<td>0-6 months</td>
</tr>
<tr>
<td class="label">Type 2</td>
<td>6-18 months</td>
</tr>
<tr>
<td class="label">Type 3</td>
<td>>18 months</td>
</tr>
<tr>
<td class="label">Type 4</td>
<td>Adult</td>
</tr>
<tr>
<td class="label">snRNP</td>
<td>Function</td>
</tr>
<tr>
<td class="label">U1 snRNP</td>
<td>5' splice site recognition</td>
</tr>
<tr>
<td class="label">U2 snRNP</td>
<td>Branch point recognition</td>
</tr>
<tr>
<td class="label">U4/U6 snRNP</td>
<td>Catalytic core formation</td>
</tr>
<tr>
<td class="label">U5 snRNP</td>
<td>Exon ligation</td>
</tr>
<tr>
<td class="label">Treatment</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Nusinersen (Spinraza)</td>
<td>ASO to promote SMN2 exon 7 inclusion</td>
</tr>
<tr>
<td class="label">Onasemnogene abeparvovec (Zolgensma)</td>
<td>Gene therapy delivering SMN1</td>
</tr>
<tr>
<td class="label">Risdiplam (Evrysdi)</td>
<td>Small molecule SMN2 splicer</td>
</tr>
<tr>
<td class="label">Treatment</td>
<td>Mechanism</td>
</tr>
<tr>
<td class="label">Nusinersen</td>
<td>ASO - SMN2 exon 7 inclusion</td>
</tr>
<tr>
<td class="label">Onasemnogene abeparvovec</td>
<td>Gene therapy - SMN1</td>
</tr>
<tr>
<td class="label">Risdiplam</td>
<td>Small molecule - SMN2 splicing</td>
</tr>
<tr>
<td class="label">Species</td>
<td>GEMIN8 Homolog</td>
</tr>
<tr>
<td class="label">Human</td>
<td>GEMIN8</td>
</tr>
<tr>
<td class="label">Mouse</td>
<td>Gemin8</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>gemin8</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Gemin8-like</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
GEMIN8 (Gem-Associated Protein 8) is a critical component of the SMN (Survival of Motor Neuron) complex, the central machinery responsible for assembling small nuclear ribonucleoproteins (snRNPs) that form the spliceosome. As one of the eight core proteins in the SMN complex, GEMIN8 plays an essential role in pre-mRNA splicing, and its dysfunction is directly linked to spinal muscular atrophy (SMA), a devastating neuromuscular disorder. The SMN complex, comprising SMN protein and Gemins 2-8, orchestrates the biogenesis of snRNPs, which are essential for spliceosomal function in all tissues, but motor neurons are particularly vulnerable to SMN deficiency. [@lunn2008]
Gene Information
Normal Function
Role in the SMN Complex
The SMN complex is a macromolecular assembly centered around the SMN protein, with GEMIN8 serving as an essential structural and functional component:
Complex Architecture:
- SMN (Survival of Motor Neuron): The central scaffolding protein
- Geminin (Gemin2, Gemin3, Gemin4): Core structural components
- Gemin5: The snRNA-binding component
- Gemin6, Gemin7: Form a heterodimer
- GEMIN8: Connects the complex to the spliceosomal components
The SMN complex mediates the assembly of snRNPs through a step-wise process:
GEMIN8 contributes to stabilizing the complex and facilitating interactions between SMN and other gemins. Studies have shown that GEMIN8 directly interacts with SMN and other Gemin proteins, forming essential contacts within the assembly machinery. [@lefebvre1995]
snRNP Biogenesis
snRNPs (small nuclear ribonucleoproteins) are the building blocks of the spliceosome:
snRNA Types:
- U1 snRNP: Recognizes 5' splice site
- U2 snRNP: Binds branch point
- U4/U5/U6 tri-snRNP: Catalytic core
- U5 snRNP: Mediates exon ligation
The proper function of the SMN complex, including GEMIN8, is absolutely essential for this process. Without functional SMN complex, snRNPs cannot form properly, leading to defective pre-mRNA splicing. [@lorson1999]
Expression Pattern
GEMIN8 is expressed ubiquitously but with tissue-specific variations:
In the nervous system, GEMIN8 is particularly important in:
- Motor neurons (the cells most affected in SMA)
- Hippocampal neurons
- Cerebellar Purkinje cells
Disease Associations
Spinal Muscular Atrophy (SMA)
SMA is an autosomal recessive neuromuscular disorder caused by deletion or mutation in the SMN1 gene, leading to insufficient SMN protein. While GEMIN8 itself is not typically mutated in SMA, its function is essential for understanding disease pathogenesis and therapeutic approaches.
Molecular Mechanisms:
Disease Spectrum:
SMA manifests across a spectrum of severity based on SMN2 copy number and residual SMN protein levels. The severity correlates with the amount of functional SMN protein present, which is determined by the number of SMN2 gene copies. [@bowerman2017]
Therapeutic Implications:
Understanding the SMN complex function, including GEMIN8's role, has led to therapeutic strategies:
- Antisense oligonucleotides (ASOs)
- Small molecules (risdiplam, nusinersen)
- Gene therapy (onasemnogene abeparvovec)
- Base editing approaches targeting the SMN2 splicing silencer
- CRISPR-based therapies
- [@alves2024] discusses optimization of base editors for SMN2 correction
- Recent research shows SMN affects SNARE assembly at neuromuscular synapses
- [@kim2023] identifies a spinal muscular atrophy modifier linking SMN to synaptic function
Neurodegeneration Mechanisms
Beyond SMA, SMN complex dysfunction has implications for broader neurodegeneration:
Splicing Defects:
- Global splicing alterations
- Specific intron retention
- Exon skipping events
- Impaired protein homeostasis
- Mitochondrial dysfunction
- Cytoskeletal abnormalities
- Synaptic defects
While SMA is primarily a developmental disorder, the spliceosomal dysfunction may have relevance to:
- Amyotrophic Lateral Sclerosis (ALS)
- Spinal bulb degeneration
- Age-related motor neuron disease
SMN Complex Architecture
GEMIN8 Position in the Complex
GEMIN8 occupies a unique structural position within the SMN complex [@winkler2005][@shao2019]:
- Core architecture: GEMIN8 forms part of the central scaffold that connects SMN to the Gemin proteins
- Geminin homology: Contains domains structurally related to geminin (an inhibitor of DNA replication)
- Oligomeric state: Forms tetramers that contribute to complex stability
- Assembly function: Critical for proper SMN complex assembly and function
SMN Complex Assembly Pathway
The SMN complex assembles through a coordinated process [@battle2006][@monahan2008]:
Structural Interactions
GEMIN8 directly interacts with:
- SMN protein (central scaffolding)
- Gemin6/Gemin7 (forming a subcomplex)
- Gemin5 (snRNA binding component)
Role in snRNP Biogenesis
snRNP Assembly Cycle
The SMN complex, including GEMIN8, orchestrates snRNP biogenesis through multiple stages [@carme2013][@counts2015]:
Stage 1: Initial Complex Formation
- SMN complex binds to snRNA (U1, U2, U4, U5, U6)
- Gemin5 provides snRNA recognition specificity
- GEMIN8 stabilizes the complex
- Sm proteins (B, B', D1, D2, D3, E, F, G) are recruited
- Ring formation around the snRNA 3' end
- GEMIN8 contributes to proper Sm protein positioning
- 3' end processing (methylation of the snRNA cap)
- Nuclear import through the Cajal body
- Additional modifications for spliceosomal activation
snRNA Specificity
The SMN complex assembles multiple snRNP types:
Neuronal Specificity
Why Motor Neurons Are Vulnerable
Motor neurons exhibit particular sensitivity to SMN complex deficiency [@sendtner2010][@martinez2018]:
Metabolic demands:
- High energy requirements for axonal transport
- Long axons requiring extensive protein synthesis locally
- High mitochondrial density
- Large genome requiring constant splicing activity
- Activity-dependent gene expression
- Synaptic plasticity mechanisms
- Extensive dendritic arborization
- Neuromuscular junction maintenance
- Axonal transport of organelles
SMN-Dependent RNA Processing in Neurons
The neuronal transcriptome requires:
- Alternative splicing for neuronal isoforms
- Activity-dependent splicing
- Long intron processing
- Non-coding RNA processing
Therapeutic Implications
GEMIN8 as Biomarker
Measuring GEMIN8 levels provides insight into:
- SMN complex integrity
- snRNP assembly efficiency
- Treatment response
- Disease progression
Combination Therapy Approaches
Understanding GEMIN8 function enables:
- Targeting multiple complex components simultaneously
- Identifying synergistic drug combinations
- Developing biomarkers for patient stratification
SMN-Independent Pathways
Research on GEMIN8 may reveal:
- Alternative splicing targets
- SMN-independent snRNP assembly pathways
- Novel therapeutic approaches for non-responders
Therapeutic Approaches
Current Treatments
GEMIN8-Specific Considerations
While GEMIN8 is not a direct therapeutic target, understanding its function informs:
Research Directions
- Developing GEMIN8 activity readouts
- Understanding tissue-specific vulnerability
- Exploring SMN-independent therapeutic pathways
- Investigating gemins as disease modifiers
GEMIN8 in Neurodegenerative Disease Research
SMN-Independent Functions
Recent research has revealed that GEMIN8, as part of the SMN complex, may have functions that extend beyond traditional snRNP assembly. These SMN-independent roles are increasingly recognized as important for understanding motor neuron vulnerability in SMA and related disorders[@imlay2016].
Non-Spliceosomal Functions:
- Regulation of neuromuscular junction formation
- Control of synaptic vesicle dynamics
- Axonal transport regulation
- Mitochondrial function maintenance
- Targeting SMN-independent pathways may provide benefits beyond SMN restoration
- Combination therapies addressing multiple pathways show promise
- Biomarkers measuring these functions may predict treatment response[@bobby2023]
SMN Complex Dynamics in Stress Conditions
The SMN complex responds to cellular stress through dynamic reorganization, which may have implications for neurodegenerative conditions beyond SMA[@cusco2019]:
Stress Response Mechanisms:
- Redistribution of SMN complex components under oxidative stress
- Alterations in snRNP assembly kinetics during cellular stress
- Compensation mechanisms that maintain spliceosomal function
- Implications for age-related neurodegeneration
- Oxidative stress effects on SMN complex stability
- Energy deprivation impact on snRNP assembly
- Metabolic stress response in motor neurons
- Potential therapeutic targeting of stress pathways
SMN Complex in Synaptic Biology
The SMN complex plays critical roles at the neuromuscular junction and central synapses, providing insight into how SMN deficiency leads to the characteristic motor symptoms of SMA[@dreyfuss2014]:
Synaptic Functions:
- SNARE complex assembly regulation
- Synaptic vesicle precursor formation
- Active zone protein localization
- Postsynaptic receptor clustering
- Impaired synaptic vesicle cycling
- Reduced neurotransmitter release
- Postsynaptic receptor instability
- NMJ maturation defects
Structural Insights into GEMIN8 Function
Recent structural studies have provided detailed insights into how GEMIN8 contributes to SMN complex function[@raker2021]:
Architecture:
- GEMIN8 forms a scaffold connecting SMN to the Gemin subcomplex
- Multiple protein-protein interaction domains
- Flexibility allowing conformational changes during assembly
- Energy-independent recruitment to the assembly complex
- Stabilization of intermediate states
- Facilitation of snRNA loading
Therapeutic Development for SMA
Current Treatment Landscape
The treatment landscape for SMA has transformed dramatically in recent years[@bobby2023]:
Clinical Outcomes:
- Significant improvement in motor function
- Extended survival in severe cases
- Variable response depending on age and severity
- Need for combination therapy approaches
Future Therapeutic Directions
SMN-Independent Approaches:
- Targeting downstream pathways affected by SMN deficiency
- Neuroprotective agents
- Muscle-strengthening therapies
- snRNP assembly efficiency markers
- Functional readouts of synaptic health
- Disease progression indicators
GEMIN8 as Research Tool
Knockdown and Overexpression Studies
Studying GEMIN8 function through experimental manipulation:
Knockdown Effects:
- Reduced snRNP assembly efficiency
- Altered splicing patterns
- Motor neuron dysfunction in model systems
- Disruption of SMN complex stoichiometry
- Impaired complex assembly kinetics
- Cellular stress responses
Model Systems
Cellular Models:
- Motor neuron differentiation from iPSCs
- Mouse primary neuron cultures
- Zebrafish motor neuron development
- Mouse models with GEMIN8 modifications
- Zebrafish knockdown models
- Drosophila SMN complex mutants
Comparative Analysis
GEMIN8 Across Species
Evolutionary Conservation:
- Core SMN complex functions conserved
- Some species-specific isoforms
- Neuronal functions particularly conserved
GEMIN8 in Disease Context
SMA Disease Spectrum:
- Correlates with residual SMN protein levels
- GEMIN8 expression affected by SMN deficiency
- Potential modifier role
- ALS and SMN complex dysfunction
- Spinal muscular atrophy with respiratory distress (SMARD1)
- Congenital myopathies
Research Challenges and Opportunities
Current Knowledge Gaps
Emerging Research Areas
Key Publications
External Links
- [NCBI Gene: GEMIN8](https://www.ncbi.nlm.nih.gov/gene/54935)
- [OMIM: 609653](https://www.omim.org/entry/609653)
- [UniProt: Q9BYX4](https://www.uniprot.org/uniprotkb/Q9BYX4/entry)
- [Ensembl: GEMIN8](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000165275)
See Also
- [SMN1 Gene](/genes/smn1) - Causative gene for SMA
- [SMN2 Gene](/genes/smn2) - Modifier gene
- [Gemin2](/proteins/gemin2-protein) - SMN complex component
- [Gemin5](/proteins/gemin5-protein) - snRNA-binding component
- [Spinal Muscular Atrophy](/diseases/spinal-muscular-atrophy) - Disease page
- [Spliceosome](/mechanisms/spliceosome-function) - Mechanism page
- [snRNP Biogenesis](/mechanisms/snrpna-biogenesis) - Mechanism page
- [SMN Complex](/mechanisms/smn-complex) - Mechanism page
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-gemin8 |
| kg_node_id | GEMIN8 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-9fe523752351 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-gemin8'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-gemin8?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[GEMIN8 Gene](http://scidex.ai/artifact/wiki-genes-gemin8)
http://scidex.ai/artifact/wiki-genes-gemin8